Trial Details
COMPLETEDBasic Information
| Clinical ID | c2065 |
|---|---|
| Identifier | NCT04023396 |
| Trial Title | Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: ABX464 |
Participant Information
| Sponsor | Abivax S.A. |
|---|---|
| City | Innsbruck |
| Country/Region | Austria |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2020-01-13 |
|---|---|
| Primary Completion Date | 2023-02-23 |
| Completion Date | 2024-03-15 |